The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of sleep quality on clinical features of primary Sjögren's syndrome

  • Chung, Sang Wan (Department of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Hur, Jaehyung (Department of Internal Medicine, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Ha, You-Jung (Department of Internal Medicine, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Kang, Eun Ha (Department of Internal Medicine, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Hyon, Joon Young (Department of Ophthalmology, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Lee, Hyo-Jung (Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Song, Yeong Wook (Department of Internal Medicine, Medical Research Institute, Seoul National University College of Medicine) ;
  • Lee, Yun Jong (Department of Internal Medicine, Section of Dentistry, Seoul National University Bundang Hospital)
  • Received : 2017.04.13
  • Accepted : 2017.11.10
  • Published : 2019.09.01
⟨ Previous Next ⟩

Abstract

Background/Aims: This study aimed to investigate the inf luence of poor sleep quality on clinical features of primary Sjögren's syndrome (pSS). Methods: Sleep quality was cross-sectionally assessed using the Pittsburgh Sleep Quality Index (PSQI), and demographic, clinical, and laboratory data were collected from 115 Korean patients with pSS. The patients completed questionnaires on the European League Against Rheumatism (EULAR) SS Patient Reported Index (ESSPRI), quality of life (EuroQOL five dimensions questionnaire [EQ-5D]), fatigue (fatigue severity score [FSS]), and depression (Beck Depression Inventory [BDI] II]). Symptoms and patient global assessment (PGA) were evaluated with a 100-mm visual analogue scale (VAS). The EULAR sicca score (ESS), ESSPRI, and EULAR SS Disease Activity Index (ESSDAI) were calculated at study enrollment. Results: Fifty-three patients (46.1%) had poor sleep quality and 32.4% of 71 patients without depression were poor sleepers. Poor sleepers had a significantly lower EQ-5D or ESSDAI and a significantly higher FSS, BDI-II, PGA, ESS, ESSPRI, or VAS scores for extra-glandular symptoms than good sleepers. Neutrophil and lymphocyte counts were significantly higher and immunoglobulin G levels tended to decrease in poor sleepers. Additionally, PSQI was negatively correlated with EQ-5D and ESSDAI and positively with ESS, FSS, BDI-II, PGA, VAS scores for their symptoms, and ESSPRI. Multivariate analysis revealed that poor sleep quality remained the independent determinants of the unsatisfactory symptom state (ESSPRI ≥ 5). Conclusions: Our results showed that poor sleep quality could significantly affect the patient-oriented outcomes and physician-reported activity index of pSS patients through the various effects of sleep quality on the psychological or somatic symptoms and the immune system.

Keywords

References

  1. Ramos-Casals M, Font J. Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology (Oxford) 2005;44:1354-1367. https://doi.org/10.1093/rheumatology/keh714
  2. Seror R, Theander E, Bootsma H, et al. Outcome measures for primary Sjogren's syndrome: a comprehensive review. J Autoimmun 2014;51:51-56. https://doi.org/10.1016/j.jaut.2013.12.010
  3. Seror R, Theander E, Brun JG, et al. Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015;74:859-866. https://doi.org/10.1136/annrheumdis-2013-204615
  4. Seror R, Ravaud P, Mariette X, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968-972. https://doi.org/10.1136/ard.2010.143743
  5. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-1109. https://doi.org/10.1136/ard.2009.110619
  6. Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009;11:R160. https://doi.org/10.1186/ar2842
  7. Palagini L, Tani C, Mauri M, et al. Sleep disorders and systemic lupus erythematosus. Lupus 2014;23:115-123. https://doi.org/10.1177/0961203313518623
  8. Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 2008;12:211-228. https://doi.org/10.1016/j.smrv.2007.09.001
  9. Ranjbaran Z, Keefer L, Stepanski E, Farhadi A, Keshavarzian A. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res 2007;56:51-57. https://doi.org/10.1007/s00011-006-6067-1
  10. Tishler M, Barak Y, Paran D, Yaron M. Sleep disturbances, fibromyalgia and primary Sjogren's syndrome. Clin Exp Rheumatol 1997;15:71-74.
  11. Gudbjornsson B, Broman JE, Hetta J, Hallgren R. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol 1993;32:1072-1076. https://doi.org/10.1093/rheumatology/32.12.1072
  12. Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM. Pain severity and neuropathic pain symptoms in primary Sjogren's syndrome: a comparison study of seropositive and seronegative Sjogren's syndrome patients. Arthritis Care Res (Hoboken) 2013;65:1291-1298. https://doi.org/10.1002/acr.21956
  13. Priori R, Minniti A, Antonazzo B, Fusconi M, Valesini G, Curcio G. Sleep quality in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2016;34:373-379.
  14. Theander L, Strombeck B, Mandl T, Theander E. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjogren's syndrome? Rheumatology (Oxford) 2010;49:1177-1183. https://doi.org/10.1093/rheumatology/keq023
  15. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558. https://doi.org/10.1136/ard.61.6.554
  16. Seror R, Bootsma H, Saraux A, et al. Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 2016;75:382-389.
  17. Sohn SI, Kim DH, Lee MY, Cho YW. The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index. Sleep Breath 2012;16:803-812. https://doi.org/10.1007/s11325-011-0579-9
  18. Omachi TA. Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S287-S296. https://doi.org/10.1002/acr.20544
  19. Lee YK, Nam HS, Chuang LH, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009;12:1187-1193. https://doi.org/10.1111/j.1524-4733.2009.00579.x
  20. Lee JH, Jeong HS, Lim SM, et al. Reliability and validity of the fatigue severity scale among university student in South Korea. Korean J Biol Psychiatry 2013;20:6-11.
  21. Sung HM, Kim JB, Park YN, Bai DS, Lee SH, Ahn HN. A study on the reliability and the validity of Korean version of the Beck Depression Inventory-II (BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14:201-212.
  22. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep 2008;31:1601-1607. https://doi.org/10.1093/sleep/31.11.1601
  23. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:46-50. https://doi.org/10.1016/S1079-2104(00)80013-X
  24. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-621. https://doi.org/10.1001/archopht.118.5.615
  25. Son CN, Choi G, Lee SY, et al. Sleep quality in rheumatoid arthritis, and its association with disease activity in a Korean population. Korean J Intern Med 2015;30:384-390. https://doi.org/10.3904/kjim.2015.30.3.384
  26. Chang KJ, Son SJ, Lee Y, et al. Perceived sleep quality is associated with depression in a Korean elderly population. Arch Gerontol Geriatr 2014;59:468-473. https://doi.org/10.1016/j.archger.2014.04.007
  27. Gandia M, Morales-Espinoza EM, Martin-Gonzalez RM, et al. Factors influencing dry mouth in patients with primary Sjogren syndrome: usefulness of the ESSPRI index. Oral Health Dent Manag 2014;13:402-407.
  28. Ayaki M, Kawashima M, Negishi K, Kishimoto T, Mimura M, Tsubota K. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. Sci Rep 2016;6:22480. https://doi.org/10.1038/srep22480
  29. Lee YB, Koh JW, Hyon JY, Wee WR, Kim JJ, Shin YJ. Sleep deprivation reduces tear secretion and impairs the tear film. Invest Ophthalmol Vis Sci 2014;55:3525-3531. https://doi.org/10.1167/iovs.14-13881
  30. Boardman HF, Thomas E, Millson DS, Croft PR. The natural history of headache: predictors of onset and recovery. Cephalalgia 2006;26:1080-1088. https://doi.org/10.1111/j.1468-2982.2006.01166.x
  31. Karageorgas T, Fragioudaki S, Nezos A, Karaiskos D, Moutsopoulos HM, Mavragani CP. Fatigue in primary Sjogren's syndrome: clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res (Hoboken) 2016;68:123-131. https://doi.org/10.1002/acr.22720
  32. Segal B, Thomas W, Rogers T, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren's syndrome. Arthritis Rheum 2008;59:1780-1787. https://doi.org/10.1002/art.24311
  33. Cho HJ, Yoo JJ, Yun CY, et al. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients. Rheumatology (Oxford) 2013;52:2208-2217. https://doi.org/10.1093/rheumatology/ket270
  34. Wu CH, Hsieh SC, Lee KL, Li KJ, Lu MC, Yu CL. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjogren's syndrome in Taiwan: a double-blind, placebo-controlled trial. J Formos Med Assoc 2006;105:796-803. https://doi.org/10.1016/S0929-6646(09)60266-7
  35. Meiners PM, Arends S, Brouwer E, Spijkervet FK, Vissink A, Bootsma H. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren's syndrome treated with rituximab. Ann Rheum Dis 2012;71:1297-1302. https://doi.org/10.1136/annrheumdis-2011-200460
  36. Strand V, van Vollenhoven RF, Lee EB, et al. Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. Rheumatology (Oxford) 2016;55:1031-1041. https://doi.org/10.1093/rheumatology/kev442
  37. Lasselin J, Rehman JU, Akerstedt T, Lekander M, Axelsson J. Effect of long-term sleep restriction and subsequent recovery sleep on the diurnal rhythms of white blood cell subpopulations. Brain Behav Immun 2015;47:93-99. https://doi.org/10.1016/j.bbi.2014.10.004
  38. Lange T, Perras B, Fehm HL, Born J. Sleep enhances the human antibody response to hepatitis A vaccination. Psychosom Med 2003;65:831-835. https://doi.org/10.1097/01.PSY.0000091382.61178.F1
  39. Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 2008;4:563-571. https://doi.org/10.5664/jcsm.27351

Cited by

  1. Measures of Sleep in Rheumatologic Diseases: Sleep Quality Patient‐Reported Outcomes in Rheumatologic Diseases vol.72, pp.suppl10, 2019, https://doi.org/10.1002/acr.24238
  2. Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjögren’s syndrome vol.16, pp.11, 2019, https://doi.org/10.1371/journal.pone.0259519